Drugs / TC-NK Infusion
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01807611 | May 2013 → Aug 2021 | leukemia, lymphoma | St. Jude Children's Research Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TC-NK Infusion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01807611 ↗ |
| Modality | Cell therapy | “Participants receive infusions of TC-NK.” NCT01807611 ↗ |